New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2013
15:23 EDTHOTT, DCTH, VRA, FTK, CWTR, MW, DBLE, BKEPCompanies reporting After the Market Close on Wednesday, March 13
Notable companies reporting after the closing bell on Wednesday include Blueknight Energy Partners (BKEP), Coldwater Creek (CWTR), Delcath Systems (DCTH), Double Eagle Petroleum (DBLE), Flotek Industries (FTK), Hot Topic (HOTT), Men's Wearhouse (MW), and Vera Bradley (VRA).
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2015
10:07 EDTDCTHDelcath Systems management to meet with Roth Capital
Subscribe for More Information
April 22, 2015
16:28 EDTFTKFlotek reports Q1 EPS (3c), consensus 14c
Reports Q1 revenue $82.4M, consensus $103.33M. The company said, "The decrease in revenue was driven by the steep decline in oilfield activity as indicated by the 25.5% decline in the average North American rig count." It added, "While we are disappointed in our first quarter results and are laser-focused on identifying best practices that will further improve our business, the rapid deterioration in oilfield activity was the primary contributor to both the decline in overall activity and resulting pricing pressures. That said, regardless of the cyclical pressures, leadership is about finding opportunities in all market environments and that is what Flotek intends to do as we continue our quest to be the premier oilfield technology company in North America and create best-in-class value for our stakeholders."
07:11 EDTDCTHCardiovascular & Interventional Radiological Society of Europe holds conference
Subscribe for More Information
April 21, 2015
09:22 EDTFTKOn The Fly: Pre-market Movers
Subscribe for More Information
08:06 EDTDCTHDelcath Systems approves amendments to its CTAs filed in U.K. and Germany
Delcath Systems announces approval of amendments to its Clinical Trial Authorizations, or CTAs, filed with the U.K.'s Medicines and Healthcare Products Regulatory Agency and Germany's Federal Institute for Drugs and Medical Devices for the expansion of the Company's global Phase 2 program for the treatment of patients with unresectable hepatocellular carcinoma, to include a cohort of patients with intrahepatic cholangiocarcinoma.
07:39 EDTFTKFlotek: Rapid deceleration in commodity had a marked impact in Q1 results
Flotek cited the rapid deceleration in commodity prices and the resulting evisceration in oilfield activity has having a marked impact in Q1 results. Expects 1H15 to be "sloppy." The company added, "The decline in revenue approximated the decline in overall oilfield activity which was much more pronounced than nearly anyone would have expected. That said, we have been through industry cycles before and are well positioned to weather the tumult of the trough and emerge as a leader in oilfield technology, with a solid balance sheet and financial position to take advantage of opportunities as the industry emerges from the depths of the current cycle... "On the chemistry front, we continue to see new validation opportunities and are working with over 40 companies in various stages of validation projects in North America. While activity and pricing has moderated for all products, we have been pleased by the continued strength in chemistry inquiries and validation projects."
07:37 EDTFTKFlotek sees Q1 enterprise-wide gross margins should exceed 32%.
Subscribe for More Information
07:37 EDTFTKFlotek sees Q1 EPS (3c), consensus 14c
Subscribe for More Information
April 17, 2015
08:08 EDTMWMen's Wearhouse recommended at Goldman
Subscribe for More Information
April 16, 2015
13:01 EDTMWJos. A. Bank to scale back on suit discounts, Business Insider reports
Men's Wearhouse is scaling back on the discounts for Jos. A. Bank, reports Business Insider. CEO Doug Ewert said the "buy-one, get-several free" deals are no longer sustainable, adding that the company "sees an opportunity to expand on other reasons to shop at Jos. A. Bank, beyond just deep discounts. Reference Link
April 14, 2015
17:00 EDTVRAVera Bradley says Chief Marketing Officer Angel Ilagan to leave
Angel Ilagan, Chief Marketing Officer of Vera Bradley, will be leaving the company effective April 17. The company has begun a search for a new Chief Marketing Officer. In the interim, Stephanie Scheele, Vice President of Marketing, will oversee the marketing area.
07:04 EDTFTKFlotek and Solazyme announce strategic agreements to develop technologies
Flotek Industries (FTK) and Solazyme (SZYM) announced the companies and certain subsidiaries have entered into agreements to globally commercialize Flocapso. In addition, Flotek will market Solazyme's Encapso lubricant - the first commercially available, biodegradable encapsulated lubricant for drilling fluids in certain Middle Eastern markets. Under the Joint Product Development and Marketing Agreement, Flotek and Solazyme will commercialize and market Flocapso, a proprietary formulation combining Flotek's patented Complex nano-Fluid chemistries with Solazyme's proprietary Encapso technology to create an environmentally-conscious, highly effective drilling fluid additive focused on better lubricity and greater stabilization for drilling programs worldwide. Laboratory and commercial testing indicate that the Flocapso additive will allow the use of water-based fluids in wells that previously required more expensive and invasive oil-based products, providing an environmentally superior, more efficient solution to drilling challenges around the globe. Under the Joint Agreement, Flotek and Solazyme will continue the development of the Flocapso chemistries and work cooperatively to market Flocapso worldwide. The companies are currently in an active validation project with a large national oil company in the Middle East and are pursuing commercial applications in both domestic and international markets.
07:04 EDTFTKFlotek, Solazyme announce agreements to commercialize Flocapso
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use